Advertisement

Clinical applications of molecular genetic discoveries

  • Ali J. Marian
    Correspondence
    Reprint requests: Ali J. Marian, Center for Cardiovascular Genetics, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Sciences Center, 6770 Bertner Street, Suite C900A, Houston, TX 77030
    Affiliations
    Center for Cardiovascular Genetics, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, Tex

    Center for Cardiovascular Genetics, Texas Heart Institute, Houston, Tex
    Search for articles by this author
Published:October 24, 2015DOI:https://doi.org/10.1016/j.trsl.2015.10.005
      Genome-wide association studies of complex traits have mapped >15,000 common single nucleotide variants (SNVs). Likewise, applications of massively parallel nucleic acid sequencing technologies often referred to as next-generation sequencing to molecular genetic studies of complex traits have catalogued a large number of rare variants (population frequency of <0.01) in cases with complex traits. Moreover, high-throughput nucleic acid sequencing, variant burden analysis, and linkage studies are illuminating the presence of large number of SNVs in cases and families with single-gene disorders. The plethora of the genetic variants has exposed the formidable challenge of identifying the causal and pathogenic variants from the enormous number of innocuous common and rare variants that exist in the population and in an individual genome. The arduous task of identifying the causal and pathogenic variants is further compounded by the pleiotropic effects of the variants, complexity of cis and trans interactions in the genome, variability in phenotypic expression of the disease, as well as phenotypic plasticity, and the multifarious determinants of the phenotype. Population genetic studies offer the initial roadmaps and have the potential to elucidate novel pathways involved in the pathogenesis of the disease. However, the genome of an individual is unique, rendering unambiguous identification of the causal or pathogenic variant in a single individual exceedingly challenging. Yet, the focus of the practice of medicine is on the individual, as Sir William Osler elegantly expressed in his insightful quotation: “The good physician treats the disease; the great physician treats the patient who has the disease.” The daunting task facing physicians, patients, and researchers alike is to apply the modern genetic discoveries to care of the individual with or at risk of the disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Iyer M.K.
        • Niknafs Y.S.
        • Malik R.
        • et al.
        The landscape of long noncoding RNAs in the human transcriptome.
        Nat Genet. 2015; 47: 199-208
        • Londin E.
        • Loher P.
        • Telonis A.G.
        • et al.
        Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.
        Proc Natl Acad Sci U S A. 2015; 112: E1106-E1115
        • Hangauer M.J.
        • Vaughn I.W.
        • McManus M.T.
        Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs.
        PLoS Genet. 2013; 9: e1003569
        • Bird A.
        Genome biology: not drowning but waving.
        Cell. 2013; 154: 951-952
        • Magny E.G.
        • Pueyo J.I.
        • Pearl F.M.
        • et al.
        Conserved regulation of cardiac calcium uptake by peptides encoded in small open reading frames.
        Science. 2013; 341: 1116-1120
        • Nelson B.R.
        • Anderson D.M.
        • Olson E.N.
        Small open reading frames pack a big punch in cardiac calcium regulation.
        Circ Res. 2014; 114: 18-20
        • Anderson D.M.
        • Anderson K.M.
        • Chang C.L.
        • et al.
        A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.
        Cell. 2015; 160: 595-606
        • Rizki G.
        • Boyer L.A.
        Lncing epigenetic control of transcription to cardiovascular development and disease.
        Circ Res. 2015; 117: 192-206
        • Djebali S.
        • Davis C.A.
        • Merkel A.
        • et al.
        Landscape of transcription in human cells.
        Nature. 2012; 489: 101-108
        • Mele M.
        • Ferreira P.G.
        • Reverter F.
        • et al.
        Human genomics. The human transcriptome across tissues and individuals.
        Science. 2015; 348: 660-665
        • ENCODE Project Consortium
        An integrated encyclopedia of DNA elements in the human genome.
        Nature. 2012; 489: 57-74
        • Rivera C.M.
        • Ren B.
        Mapping human epigenomes.
        Cell. 2013; 155: 39-55
        • Kong A.
        • Frigge M.L.
        • Masson G.
        • et al.
        Rate of de novo mutations and the importance of father's age to disease risk.
        Nature. 2012; 488: 471-475
        • Genomes Project C.
        • Abecasis G.R.
        • Altshuler D.
        • et al.
        A map of human genome variation from population-scale sequencing.
        Nature. 2010; 467: 1061-1073
        • Francioli L.C.
        • Polak P.P.
        • Koren A.
        • et al.
        Genome-wide patterns and properties of de novo mutations in humans.
        Nat Genet. 2015; 47: 822-826
        • Conrad D.F.
        • Keebler J.E.
        • DePristo M.A.
        • et al.
        Variation in genome-wide mutation rates within and between human families.
        Nat Genet. 2011; 43: 712-714
        • Kloosterman W.P.
        • Francioli L.C.
        • Hormozdiari F.
        • et al.
        Characteristics of de novo structural changes in the human genome.
        Genome Res. 2015; 25: 792-801
        • Sun J.X.
        • Helgason A.
        • Masson G.
        • et al.
        A direct characterization of human mutation based on microsatellites.
        Nat Genet. 2012; 44: 1161-1165
        • Keinan A.
        • Clark A.G.
        Recent explosive human population growth has resulted in an excess of rare genetic variants.
        Science. 2012; 336: 740-743
        • Tennessen J.A.
        • Bigham A.W.
        • O'Connor T.D.
        • et al.
        Evolution and functional impact of rare coding variation from deep sequencing of human exomes.
        Science. 2012; 337: 64-69
        • Novembre J.
        • Johnson T.
        • Bryc K.
        • et al.
        Genes mirror geography within Europe.
        Nature. 2008; 456: 98-101
        • Levy S.
        • Sutton G.
        • Ng P.C.
        • et al.
        The diploid genome sequence of an individual human.
        PLoS Biol. 2007; 5: e254
        • Wheeler D.A.
        • Srinivasan M.
        • Egholm M.
        • et al.
        The complete genome of an individual by massively parallel DNA sequencing.
        Nature. 2008; 452: 872-876
        • Kidd J.M.
        • Cooper G.M.
        • Donahue W.F.
        • et al.
        Mapping and sequencing of structural variation from eight human genomes.
        Nature. 2008; 453: 56-64
        • Wang J.
        • Wang W.
        • Li R.
        • et al.
        The diploid genome sequence of an Asian individual.
        Nature. 2008; 456: 60-65
        • Korbel J.O.
        • Urban A.E.
        • Affourtit J.P.
        • et al.
        Paired-end mapping reveals extensive structural variation in the human genome.
        Science. 2007; 318: 420-426
        • Sudmant P.H.
        • Mallick S.
        • Nelson B.J.
        • et al.
        Global diversity, population stratification, and selection of human copy-number variation.
        Science. 2015; 349: aab3761
        • Marian A.J.
        Nature's genetic gradients and the clinical phenotype.
        Circ Cardiovasc Genet. 2009; 2: 537-539
        • Marian A.J.
        Molecular genetic studies of complex phenotypes.
        Transl Res. 2012; 159: 64-79
        • Lange L.A.
        • Hu Y.
        • Zhang H.
        • et al.
        Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.
        Am J Hum Genet. 2014; 94: 233-245
        • Kathiresan S.
        • Willer C.J.
        • Peloso G.M.
        • et al.
        Common variants at 30 loci contribute to polygenic dyslipidemia.
        Nat Genet. 2009; 41: 56-65
        • Willer C.J.
        • Schmidt E.M.
        • Sengupta S.
        • et al.
        • Global Lipids Genetics Consortium
        Discovery and refinement of loci associated with lipid levels.
        Nat Genet. 2013; 45: 1274-1283
        • Wain L.V.
        • Verwoert G.C.
        • O'Reilly P.F.
        • et al.
        Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.
        Nat Genet. 2011; 43: 1005-1011
        • Ehret G.B.
        • Munroe P.B.
        • Rice K.M.
        • et al.
        • International Consortium for Blood Pressure Genome-Wide Association Studies
        Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.
        Nature. 2011; 478: 103-109
        • Tzur S.
        • Rosset S.
        • Shemer R.
        • et al.
        Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
        Hum Genet. 2010; 128: 345-350
        • Genovese G.
        • Friedman D.J.
        • Ross M.D.
        • et al.
        Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
        Science. 2010; 329: 841-845
        • Parsa A.
        • Kao W.H.
        • Xie D.
        • et al.
        APOL1 risk variants, race, and progression of chronic kidney disease.
        N Engl J Med. 2013; 369: 2183-2196
        • Ito K.
        • Bick A.G.
        • Flannick J.
        • et al.
        Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
        Circ Res. 2014; 114: 845-850
        • Langefeld C.D.
        • Divers J.
        • Pajewski N.M.
        • et al.
        Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
        Kidney Int. 2015; 87: 169-175
        • Forget B.G.
        • Bunn H.F.
        Classification of the disorders of hemoglobin.
        Cold Spring Harb Perspect Med. 2013; 3: a011684
        • Villard E.
        • Tiret L.
        • Visvikis S.
        • Rakotovao R.
        • Cambien F.
        • Soubrier F.
        Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis.
        Am J Hum Genet. 1996; 58: 1268-1278
        • MacArthur D.G.
        • Manolio T.A.
        • Dimmock D.P.
        • et al.
        Guidelines for investigating causality of sequence variants in human disease.
        Nature. 2014; 508: 469-476
        • Xue Y.
        • Chen Y.
        • Ayub Q.
        • et al.
        Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.
        Am J Hum Genet. 2012; 91: 1022-1032
        • Bell C.J.
        • Dinwiddie D.L.
        • Miller N.A.
        • et al.
        Carrier testing for severe childhood recessive diseases by next-generation sequencing.
        Sci Transl Med. 2011; 3: 65ra4
        • Norton N.
        • Robertson P.D.
        • Rieder M.J.
        • et al.
        Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era.
        Circ Cardiovasc Genet. 2012; 5: 167-174
        • Marian A.J.
        • Belmont J.
        Strategic approaches to unraveling genetic causes of cardiovascular diseases.
        Circ Res. 2011; 108: 1252-1269
        • Marian A.J.
        • Roberts R.
        On Koch's postulates, causality and genetics of cardiomyopathies.
        J Mol Cell Cardiol. 2002; 34: 971-974
        • Marian A.J.
        Causality in genetics: the gradient of genetic effects and back to Koch's postulates of causality.
        Circ Res. 2014; 114: e18-e21
        • Wehby G.L.
        • Ohsfeldt R.L.
        • Murray J.C.
        ‘Mendelian randomization’ equals instrumental variable analysis with genetic instruments.
        Stat Med. 2008; 27: 2745-2749
        • Chen S.N.
        • Czernuszewicz G.
        • Tan Y.
        • et al.
        Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy.
        Circ Res. 2012; 111: 907-919
        • Denker A.
        • de Laat W.
        A long-distance chromatin affair.
        Cell. 2015; 162: 942-943
        • Waszak S.M.
        • Delaneau O.
        • Gschwind A.R.
        • et al.
        Population variation and genetic control of modular chromatin architecture in humans.
        Cell. 2015; 162: 1039-1050
        • Grubert F.
        • Zaugg J.B.
        • Kasowski M.
        • et al.
        Genetic control of chromatin states in humans involves local and distal chromosomal interactions.
        Cell. 2015; 162: 1051-1065
        • Kathiresan S.
        • Melander O.
        • Guiducci C.
        • et al.
        Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
        Nat Genet. 2008; 40: 189-197
        • Kathiresan S.
        • Voight B.F.
        • Purcell S.
        • et al.
        • Myocardial Infarction Genetics Consortium
        Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.
        Nat Genet. 2009; 41: 334-341
        • Strong A.
        • Patel K.
        • Rader D.J.
        Sortilin and lipoprotein metabolism: making sense out of complexity.
        Curr Opin Lipidol. 2014; 25: 350-357
        • Korf B.R.
        • Berry A.B.
        • Limson M.
        • et al.
        Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics.
        Genet Med. 2014; 16: 804-809
        • Abifadel M.
        • Varret M.
        • Rabes J.P.
        • et al.
        Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
        Nat Genet. 2003; 34: 154-156
        • Sabatine M.S.
        • Giugliano R.P.
        • Wiviott S.D.
        • et al.
        Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
        N Engl J Med. 2015; 372: 1500-1509
        • Robinson J.G.
        • Farnier M.
        • Krempf M.
        • et al.
        Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
        N Engl J Med. 2015; 372: 1489-1499